CSI Market
Sign In | Register

Pfizer Inc (PFE) Annual Income Statement

Annual · GAAP · USD millions
Access PFE quarterly income statements →
From Pfizer Inc through Dec 31 2021, changes in Dec 31 2025's revenue and cost structure provide insight into profitability trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
2025 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax51,663.00
Total Revenue62,579.00
Costs & Expenses
Cost of Goods and Services Sold16,067.00
Gross Profit46,512.00
Selling, Administration, Marketing13,794.00
Depreciation & Amortization4,874.00
Research & Development10,437.00
Restructuring Charges AndAcquisition Related Costs1,550.00
Total operating costs including COS46,722.00
Operating income / -loss15,857.00
Net Interest (-)Expense / Income0.00
Other loss/ -income8,337.00
Total costs & expenses55,059.00
Income & Taxes
Income / -loss before income taxes7,520.00
Income taxes expenses / -benefit-266.00
Income after income taxes7,787.00
Net income / -loss of other equity1.00
Income / -loss from continuing operations7,787.00
Discontinued operations25.00
Non-controlling interests41.00
Net income / -loss7,812.00
Income / -loss to shareholder7,771.00
EBIT7,520.00
EBITD14,112.00
EBITDA14,112.00
Earnings Per Share
Basic EPS (excl. extra items)1.37
Extraordinary items0.00
Basic Net EPS1.37
Basic shares outstanding (Mill. of Units)5,683.00
Diluted Net EPS1.36
Diluted average shares (Mill. of Units)5,713.00
Dividend per share1.72
4 historic quarters locked

Sign in to unlock the full Pfizer Inc income statement history.

Sign In Create Free Account

About Pfizer Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: February 26, 2026
  • Original filing: pfe-20251231.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.